B
BioLineRx Ltd. (BLRX)
NCM – Real Time Price. Currency in USD
3.17
+0.10 (3.20%)
At close: Jun 26, 2026, 4:00 PM EDT
3.18
+0.02 (0.47%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
3.17
+0.10 (3.20%)
At close: Jun 26, 2026, 4:00 PM EDT
3.18
+0.02 (0.47%)
After-hours: Jun 26, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
Total debt $9.1M significantly exceeds cash reserves ($2.5M), raising financial stability concerns
Total current assets $21.6M exceed Total current liabilities $13.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.4) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-12.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$2.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.58 | 6.05 | 8.0 | |
| Quick ratio | 1.43 | 5.63 | 7.0 | |
| Debt to Equity | 0.54 | 0.30 | 7.0 | |
| Debt to Assets | 0.23 | 1.04 | 7.0 | |
| Interest coverage | -12.02 | -16.91 | 1.0 | |
| Weighted average score | 6.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 5M | 29M | 1M | 1M |
| Gross Profit | -651K | 174K | 19M | 430K | 667K |
| Operating Income | -29M | -43M | -19M | -10M | -11M |
| Net Income | -25M | -60M | -9M | -1M | -9M |
| EBITDA | -28M | -41M | -15M | -10M | -11M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 40.95 | N/A | 5.5 |
| Next quarter | -11.94 | N/A | 1.0 |
| Current year | 51.23 | N/A | 5.5 |
| Next year | 12.55 | 31.18 | 9.0 |
| Weighted average score | 5.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 143.69 | -85.19 | 100 | 29.94 | 7.8 |
| Y/Y | 87.53 | -150.59 | 999 | 12.01 | 7.0 |
| 3y average | 470.15 | 9.55 | 27.78 | 0.17 | 7.0 |
| 5y average | 681.69 | 9.46 | 35 | -2.34 | 6.8 |
| Weighted average score | 7.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |